Physician profile
Azem Chami
NPI 1073066247
$8,583.18
in general payments reported to CMS, 2019-2025
13 companies · $569 in 2025
The $569 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $5,115 · 2021: $660 · 2022: $423 · 2023: $1,360 · 2024: $456 · 2025: $569.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,975 · Travel and Lodging: $410.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,975.12 |
| Travel and Lodging | $410.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $5,000.00 | 2020 | |
| Boston Scientific Corporation | $1,913.05 | 2020-2025 | Wavewriter Alpha Prime 16, General - Pain Management, Intracept |
| Medtronic, INC. | $501.70 | 2021-2024 | Intellis Adaptivestim, Synchromedii |
| Abbott Laboratories | $466.29 | 2021-2025 | Eterna |
| Saluda Medical Americas, INC. | $313.96 | 2023-2024 | Evoke Scs, Evoke |
| Curonix LLC | $214.34 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Averitas Pharma INC. | $58.95 | 2023 | Qutenza |
| Scilex Pharmaceuticals INC. | $23.37 | 2022 | |
| Avanos Medical | $21.26 | 2021 | |
| Fisher & Paykel Healthcare INC | $18.55 | 2025 | Fisher & Paykel Healthcare |
| Biohaven Pharmaceuticals, INC. | $17.40 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $17.24 | 2025 | |
| Nevro Corp. | $17.07 | 2024 | Senza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Azem Chami listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.